U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07602842) titled 'A Study of IDP-001 in Advanced or Metastatic Solid Tumors' on May 08.
Brief Summary: This clinical study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of IDP-001 in participants with advanced or metastatic squamous and non-squamous NSCLC and other squamous cell solid tumors (for example, head and neck, esophageal, cervical, cutaneous).
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumor
Metastatic Solid Tumor
Head and Neck Squamous Cell Carcinoma
Cutaneous Squamous Cell Carcinoma
Squamous Cell Carcinoma of the Cervix
Non Squamous Non Small Ce...